Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study.

Diabetes care - 1 Sept 2016

Vehik Kendra, Lynch Kristian F, Schatz Desmond A, Akolkar Beena, Hagopian William, Rewers Marian, She Jin-Xiong, Simell Olli, Toppari Jorma, Ziegler Anette-G, Lernmark Åke, Bonifacio Ezio, Krischer Jeffrey P

Abstract excerpt

OBJECTIVE: β-Cell autoantibodies are a feature of the preclinical phase of type 1 diabetes. Here, we asked how frequently they revert in a cohort of children at risk for type 1 diabetes and whether reversion has any effect on type 1 diabetes risk. RESEARCH DESIGN AND METHODS: Children were up to 10 years of age and screened more than once for insulin autoantibody, GAD antibody, and insulinoma antigen-2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Autoimmunity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 1

Share to Glutamate Decarboxylase

Share to Insulin

Share to Insulin Antibodies

Share to Insulin-Secreting Cells

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 27311490
DOI: 10.2337/dc16-0181
PMCID: PMC5001144

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study.PMID 27311490Read ↗

Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY).Semantic proximity Read ↗

Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.Semantic proximity Read ↗

Predictors of the Initiation of Islet Autoimmunity and Progression to Multiple Autoantibodies and Clinical Diabetes: The TEDDY Study.Semantic proximity Read ↗

Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study.Semantic proximity Read ↗

The Influence of Type 1 Diabetes Genetic Susceptibility Regions, Age, Sex, and Family History on the Progression From Multiple Autoantibodies to Type 1 Diabetes: A TEDDY Study Report.Semantic proximity Read ↗

Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).Semantic proximity Read ↗

Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and HLA-DQ Genotype in a Registry-Based Group of Children and Adults With a First-Degree Relative With Type 1 DiabetesSemantic proximity Read ↗

Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children.Semantic proximity Read ↗

Data-Driven Phenotyping of Presymptomatic Type 1 Diabetes Using Longitudinal Autoantibody Profiles.Semantic proximity Read ↗

Late-onset islet autoimmunity in childhood: the Diabetes Autoimmunity Study in the Young (DAISY).Semantic proximity Read ↗

Family history of type 2 diabetes delays development of type 1 diabetes in TEDDY children with islet autoimmunity.Semantic proximity Read ↗

Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.